These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35530022)

  • 1. Trends in Mortality From Novel Psychoactive Substances as "Legal Highs": Gender Differences in Manner of Death and Implications for Risk Differences for Women.
    Webb L; Shi X; Goodair C; Cheeta S
    Front Psychiatry; 2022; 13():890840. PubMed ID: 35530022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016.
    Deen AA; Claridge H; Treble RD; Hamnett HJ; Copeland CS
    J Psychopharmacol; 2021 Nov; 35(11):1315-1323. PubMed ID: 34182812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality related to novel psychoactive substances in Scotland, 2012: an exploratory study.
    McAuley A; Hecht G; Barnsdale L; Thomson CS; Graham L; Priyadarshi S; Robertson JR
    Int J Drug Policy; 2015 May; 26(5):461-7. PubMed ID: 25477285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
    Napoletano S; Basile G; Lo Faro AF; Negro F
    Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic Cannabinoid-Related Deaths in England, 2012-2019.
    Yoganathan P; Claridge H; Chester L; Englund A; Kalk NJ; Copeland CS
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):516-525. PubMed ID: 33998886
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment.
    Specka M; Kuhlmann T; Sawazki J; Bonnet U; Steinert R; Cybulska-Rycicki M; Eich H; Zeiske B; Niedersteberg A; Schaaf L; Scherbaum N
    Front Psychiatry; 2020; 11():569. PubMed ID: 32733288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of psychiatric inpatients diagnosed with mental and behavioral disorders caused by psychoactive substances (F11-19 block), with a focus on NPS and psychiatric co-morbidities.
    Engelgardt P; Krzyżanowski M; Piotrowski P; Borkowska-Sztachańska M; Wasilewska A; Kowalkowski T
    Int J Occup Med Environ Health; 2020 Mar; 33(2):125-136. PubMed ID: 31942874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
    Gray R; Bressington D; Hughes E; Ivanecka A
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forensic-psychiatric relationships in the context of forensic medical examination of new psychoactive substance-related deaths.
    Rojek S; Maciów-Głąb M; Kula K; Romańczuk A; Synowiec K
    Arch Med Sadowej Kryminol; 2020; 70(4):202-221. PubMed ID: 34431645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance for Violent Deaths - National Violent Death Reporting System, 48 States, the District of Columbia, and Puerto Rico, 2020.
    Liu GS; Nguyen BL; Lyons BH; Sheats KJ; Wilson RF; Betz CJ; Fowler KA
    MMWR Surveill Summ; 2023 May; 72(5):1-38. PubMed ID: 37220104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances.
    Corkery JM; Schifano F; Martinotti G
    Br J Clin Pharmacol; 2020 Mar; 86(3):482-498. PubMed ID: 31770457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Hot" and "Cold" Cognition in Users of Club Drugs/Novel Psychoactive Substances.
    Savulich G; Bowden-Jones O; Stephenson R; Brühl AB; Ersche KD; Robbins TW; Sahakian BJ
    Front Psychiatry; 2021; 12():660575. PubMed ID: 33841219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the UK Psychoactive Substances Act 2016 on episodes of toxicity related to new psychoactive substances as reported to the National Poisons Information Service. A time series analysis.
    Al-Banaa I; Hawkins L; Hill SL; Lupton DJ; Jackson G; Sandilands EA; Bradberry SM; Thompson JP; Rushton S; Thomas SHL
    Int J Drug Policy; 2020 Mar; 77():102672. PubMed ID: 32032867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of NPS use in patients admitted to acute psychiatric services in Southeast Scotland: a retrospective cross-sectional analysis following public health interventions.
    Bennett KH; Hare HM; Waller RM; Alderson HL; Lawrie S
    BMJ Open; 2017 Dec; 7(12):e015716. PubMed ID: 29203502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
    Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
    Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal poisoning in drug addicts in the Nordic countries in 2017.
    Simonsen KW; Kriikku P; Thelander G; Edvardsen HME; Thordardottir S; Andersen CU; Jönsson AK; Frost J; Christoffersen DJ; Delaveris GJM; Ojanperä I
    Forensic Sci Int; 2020 Aug; 313():110343. PubMed ID: 32563797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of ethylphenidate in deaths in east and west Scotland.
    Parks C; McKeown D; Torrance HJ
    Forensic Sci Int; 2015 Dec; 257():203-208. PubMed ID: 26375622
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.